Download
s11523-021-00792-8.pdf 1,15MB
WeightNameValue
1000 Titel
  • Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
1000 Autor/in
  1. Gassenmaier, Maximilian |
  2. Lenders, Max M. |
  3. Forschner, Andrea |
  4. Leiter, Ulrike |
  5. Weide, Benjamin |
  6. Garbe, Claus |
  7. Eigentler, Thomas K. |
  8. Wagner, Nikolaus |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-08
1000 Erschienen in
1000 Quellenangabe
  • 16(2):197-205
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11523-021-00792-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935737/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Despite impressive response rates, most patients with advanced melanoma ultimately progress following therapy with B-Raf proto-oncogene (BRAF) inhibitors (BRAFi). Therefore, frequent radiologic assessments are necessary, and reliable serum biomarkers would be beneficial for disease monitoring.!##!Objective!#!This study investigated the ability of lactate dehydrogenase (LDH) and S100 calcium-binding protein B (S100B) to detect response and disease progression during treatment with BRAFi.!##!Patients and methods!#!Baseline levels of LDH and S100B and repeated measurements during therapy were recorded retrospectively in 191 patients with metastatic melanoma. LDH and S100B levels were compared between distinct time points (baseline, first follow-up visit [FV], best objective response [BR], and progressive disease [PD]). The prognostic ability of the serum biomarkers in relation to disease-specific survival (DSS) was assessed with univariable and multivariable Cox regression analysis.!##!Results!#!Elevated baseline LDH and S100B correlated with impaired DSS. In contrast with LDH (P = 0.12), S100B levels at FV correlated with response (P = 0.0030). Both markers significantly decreased during the first weeks of BRAFi treatment (LDH, P = 0.00034; S100B, P < 0.0001) and increased between BR and PD (LDH, P = 0.016; S100B, P < 0.0001). Patients with elevated S100B (P = 0.00062) but not with elevated LDH (P = 0.067) at the time point of radiologically confirmed PD showed significantly impaired DSS after PD. Interestingly, DSS after PD differed significantly according to S100B levels determined as early as 8 weeks (median) before PD (P = 0.0024).!##!Conclusions!#!LDH and S100B are suitable serum biomarkers during therapy with BRAFi. S100B shows stronger correlation with response and exhibits more accuracy in predicting PD. Close biomarker monitoring with S100B is recommended during treatment with BRAFi to detect PD early.
1000 Sacherschließung
lokal Proto-Oncogene Proteins B-raf/antagonists
lokal Protein Kinase Inhibitors/pharmacology [MeSH]
lokal Humans [MeSH]
lokal S100 Calcium Binding Protein beta Subunit/metabolism [MeSH]
lokal Treatment Outcome [MeSH]
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Oncology
lokal Protein Kinase Inhibitors/therapeutic use [MeSH]
lokal L-Lactate Dehydrogenase/blood [MeSH]
lokal Male [MeSH]
lokal Prognosis [MeSH]
lokal Biomedicine, general
lokal Original Research Article
lokal Melanoma/drug therapy [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R2Fzc2VubWFpZXIsIE1heGltaWxpYW4=|https://frl.publisso.de/adhoc/uri/TGVuZGVycywgTWF4IE0u|https://frl.publisso.de/adhoc/uri/Rm9yc2NobmVyLCBBbmRyZWE=|https://frl.publisso.de/adhoc/uri/TGVpdGVyLCBVbHJpa2U=|https://frl.publisso.de/adhoc/uri/V2VpZGUsIEJlbmphbWlu|https://frl.publisso.de/adhoc/uri/R2FyYmUsIENsYXVz|https://frl.publisso.de/adhoc/uri/RWlnZW50bGVyLCBUaG9tYXMgSy4=|https://orcid.org/0000-0003-4708-2886
1000 Hinweis
  • DeepGreen-ID: 4afb423ffcf344cba7806b41ab548866 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6464901.rdf
1000 Erstellt am 2023-11-16T08:23:11.475+0100
1000 Erstellt von 322
1000 beschreibt frl:6464901
1000 Zuletzt bearbeitet Fri Dec 01 01:06:36 CET 2023
1000 Objekt bearb. Fri Dec 01 01:06:36 CET 2023
1000 Vgl. frl:6464901
1000 Oai Id
  1. oai:frl.publisso.de:frl:6464901 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source